Cart
sales@molnova.com
MDK-6983
CAS No. 1227476-98-3
MDK-6983( Autophagy inhibitor 6k | Compound 6k | MDK-6983 | MDK 6983 | MDK6983 )
Catalog No. M27899 CAS No. 1227476-98-3
MDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 283 | In Stock |
|
| 5MG | 249 | In Stock |
|
| 10MG | 368 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1032 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMDK-6983
-
NoteResearch use only, not for human use.
-
Brief DescriptionMDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
-
DescriptionMDK-6983 is an inhibitor of autophagy and disrupts the dynamics of actin cytoskeleton in human melanoma cells.
-
In Vitro——
-
In Vivo——
-
SynonymsAutophagy inhibitor 6k | Compound 6k | MDK-6983 | MDK 6983 | MDK6983
-
PathwayAutophagy
-
TargetAutophagy
-
Recptormicrotubule
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1227476-98-3
-
Formula Weight429.3
-
Molecular FormulaC22H18Cl2N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOc1ccc(Cl)cc1C(=O)N[C@H](Cc1ccccc1)C(=O)Nc1ccc(Cl)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wood AC, et al. Initial testing (Stage 1) of the antibody-maytansinoid conjugate, IMGN901 (Lorvotuzumab mertansine), by the pediatric preclinical testing program. Pediatr Blood Cancer. 2013;60(11):1860-1867.
molnova catalog
related products
-
SMER-28
A small-molecule enhancer/inducer of Autophagy; decreases the levels of Aβ peptide (EC50=10 uM) and APP-CTF (EC50 of 20 uM) in a γ-secretase-independent manner in primary neuronal cultures, Atg5, Beclin1 and Ulk1 are shown to be involved in the degradation of Aβ and APP-CTF.
-
UVI 3003
UVI 3003 is a highly selective antagonist of the retinoid X receptor. UVI 3003 inhibits Xenopus and human RXRα in Cos7 cells (IC50s: 0.22 and 0.24 μM, respectively).
-
Graveoline
Graveoline is an apoptosis and autophagy inducer in skin melanoma cancer cells.
